Ondansetron HCL 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F8AFK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,841
Award facts
- Contract value 100% obligated
- $16,840.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $16,840.71 delivery order to Amerisourcebergen Drug Corp on March 6, 2026, for Ondansetron HCL 4 mg tablets (30-count). The order is firm fixed price with an ultimate completion date of March 9, 2026.
Place of performance is Conshohocken, PA. The order was not set-aside and carries no set-aside designation.
Quick answers
Who was awarded contract SPE2DR26F8AFK?
SPE2DR26F8AFK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 6, 2026.
How much is contract SPE2DR26F8AFK worth?
The government has obligated $16,841 on SPE2DR26F8AFK.
Is contract SPE2DR26F8AFK an order under another contract?
Yes. SPE2DR26F8AFK is a delivery order under SPE2DR25D7066, an indefinite delivery contract.
Was contract SPE2DR26F8AFK competed?
The extent of competition for SPE2DR26F8AFK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award